Rocket Pharmaceuticals, Inc. (RCKT)
2.385
-0.05
(-2.05%)
USD |
NASDAQ |
Nov 06, 16:00
2.385
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Total Long Term Debt (Quarterly) : 23.76M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.76M |
| March 31, 2026 | 23.77M |
| December 31, 2025 | 23.87M |
| September 30, 2025 | 24.03M |
| June 30, 2025 | 24.19M |
| March 31, 2025 | 24.35M |
| December 31, 2024 | 24.50M |
| September 30, 2024 | 24.64M |
| June 30, 2024 | 24.76M |
| March 31, 2024 | 24.88M |
| December 31, 2023 | 24.12M |
| September 30, 2023 | 24.10M |
| June 30, 2023 | 24.15M |
| March 31, 2023 | 24.55M |
| December 31, 2022 | 22.09M |
| September 30, 2022 | 21.46M |
| June 30, 2022 | 21.53M |
| March 31, 2022 | 21.60M |
| December 31, 2021 | 21.74M |
| September 30, 2021 | 21.68M |
| June 30, 2021 | 26.93M |
| March 31, 2021 | 62.51M |
| December 31, 2020 | 61.07M |
| September 30, 2020 | 68.07M |
| June 30, 2020 | 67.46M |
| Date | Value |
|---|---|
| March 31, 2020 | 67.04M |
| December 31, 2019 | 46.49M |
| September 30, 2019 | 45.79M |
| June 30, 2019 | 45.11M |
| March 31, 2019 | 44.47M |
| December 31, 2018 | 41.45M |
| September 30, 2018 | 40.63M |
| June 30, 2018 | 39.84M |
| March 31, 2018 | 39.08M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 49.39M |
| June 30, 2017 | 49.24M |
| March 31, 2017 | 49.10M |
| December 31, 2016 | 48.96M |
| September 30, 2016 | 48.82M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 17.49M |
| March 31, 2015 | 19.09M |
| December 31, 2014 | 5.613M |
| September 30, 2014 | 6.274M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.053B |
| Intellia Therapeutics, Inc. | 209.16M |
| Beam Therapeutics, Inc. | 228.23M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |